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Abstract
Background: Fungi are the second most abundant type of human pathogens. Invasive fungal pathogens are leading
causes of life-threatening infections in clinical settings. Toxicity to the host and drug-resistance are two major
deleterious issues associated with existing antifungal agents. Increasing a host’s tolerance and/or immunity to fungal
pathogens has potential to alleviate these problems. A host’s tolerance may be improved by modulating the immune
system such that it responds more rapidly and robustly in all facets, ranging from the recognition of pathogens to
their clearance from the host. An understanding of biological processes and genes that are perturbed during
attempted fungal exposure, colonization, and/or invasion will help guide the identification of endogenous
immunomodulators and/or small molecules that activate host-immune responses such as specialized adjuvants.
Results: In this study, we present computational techniques and approaches using publicly available transcriptional
data sets, to predict immunomodulators that may act against multiple fungal pathogens. Our study analyzed data sets
derived from host cells exposed to five fungal pathogens, namely, Alternaria alternata, Aspergillus fumigatus, Candida
albicans, Pneumocystis jirovecii, and Stachybotrys chartarum. We observed statistically significant associations between
host responses to A. fumigatus and C. albicans. Our analysis identified biological processes that were consistently
perturbed by these two pathogens. These processes contained both immune response-inducing genes such as
MALT1, SERPINE1, ICAM1, and IL8, and immune response-repressing genes such as DUSP8, DUSP6, and SPRED2. We
hypothesize that these genes belong to a pool of common immunomodulators that can potentially be activated or
suppressed (agonized or antagonized) in order to render the host more tolerant to infections caused by A. fumigatus
and C. albicans.
Conclusions: Our computational approaches and methodologies described here can now be applied to newly
generated or expanded data sets for further elucidation of additional drug targets. Moreover, identified
immunomodulators may be used to generate experimentally testable hypotheses that could help in the discovery of
broad-spectrum immunotherapeutic interventions. All of our results are available at the following supplementary
website: http://bioinformatics.cs.vt.edu/~murali/supplements/2013-kidane-bmc
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Background
Fungi are the second most abundant pathogens, account-
ing for 307 of the 1,407 species of recognized human
infectious pathogens [1]. Health-related impacts of fun-
gal pathogens have increased over the past several years.
For instance, in the years from 2000 to 2005, the frac-
tion of people who were admitted to hospitals primarily
due to the presence of Candida species in their blood
increased by 52% [2]. Furthermore, mortality rates from
invasive fungal infections has increased by 320% from
1980 through 1997 in the United States alone [3]. An
increase in immunocompromised individuals, prevalence
of cancer, chemotherapy treatments, organ transplanta-
tion, and autoimmune diseases are major factors that have
contributed to the rise in opportunistic fungal infections
[4].
Despite the medical importance of fungal pathogens,
the discovery and development of new antifungal agents
has been very slow. There are only four major classes
of antifungals for the treatment of systemic infections,
namely, fluoropyrimidine analogs, polyenes, azoles, and
echinocandins [5]. Fungal and human cells have simi-
lar cellular structure and molecular machinery. Conse-
quently, the number of fungal-specific targets are few,
partly contributing to the shortage of antifungal drugs [6].
Even for approved drugs, e.g., polyenes, toxicity to the
host has been a major problem [7]. Over the past two
decades, drug resistant fungal pathogens have emerged,
resistance of Candida species to azoles being the most
common type [8]. Recent examples of drug-resistant fun-
gal pathogens include multidrug resistant C. glabrata
and azole-resistant central nervous system infections by
A. fumigatus [9]
There are two potential immunomodulatory mecha-
nisms for the treatment of fungal infections: (1) decreas-
ing pathogen load by enhancing clearance of the pathogen
from the host and (2) increasing the ability of the host to
limit the health impacts of pathogens by making the host
more tolerant to infections [10]. The host’s defense capac-
ity primarily constitutes the sum of these two mecha-
nisms. Therapeutic strategies thatmerely focus on directly
killing or eradicating pathogens from host cells are prone
to the development of drug resistance. On the contrary,
strategies that target host tolerance were shown to be
viable approaches to circumvent the problem of drug
resistance [11].
A host’s tolerance to pathogens can be improved by
modulating the immune system so that it responds rapidly
and robustly in all facets, ranging from the recognition
of pathogens to their clearance from the host. For exam-
ple, this strategy may involve the use of granulocyte
colony stimulating factor (G-CSF) to increase the activa-
tion of immune cells such as neutrophils, macrophages,
and dendritic cells or the activation of toll-like receptors
to promote the recognition of pathogens. Strategies may
also involve the use of vaccines to increase the host’s
humoral immunity [12], which is an antibody-mediated
immunity, but this approach may have limitations in the
context of immunosuppression. For instance, mice that
are deficient in pentraxin 3, a gene involved in pathogen
recognition, have been shown to be more susceptible
to A. fumigatus infection [13]. In another study, the
administration of pentraxin 3 improved survival rate of
immunocompromised rats infected with A. fumigatus and
decreased the overall fungal burden [14]. Another exam-
ple is the use of thymosin α1 (Tα1), a naturally occurring
thymic peptide that was shown to facilitate the induction
of interleukin 12 (IL-12) and the functional maturation
of dendritic cells [15]. Following this study, chemically
synthesized molecules have become available e.g., Thy-
malfasin which mimics the human Thymosin α1. The
benefit of immunomodulatory agents may be maximized
by designing them so that they can be effective against
multiple pathogens. For instance, activation of antifungal
CD4+ Th1 immunity using epitope p41 of A. fumiga-
tus extracellular cell wall glucanase Crf1 succeeded in
improving outcomes in both invasive aspergillosis and
candidiasis [16].
An understanding of biological processes and genes
that are perturbed during fungal exposure, coloniza-
tion, and/or invasion will help guide identification and
development of therapies that are targeted to enhance
the hosts’ tolerance against fungal pathogens. In this
study, we present computational techniques to predict
immunomodulators that can act against multiple fungal
pathogens, based on publicly available transcriptional data
sets.
Results and discussion
We obtained genome-wide transcriptional data sets of
host responses upon exposure to fungal pathogens
from the NCBI’s Gene Expression Omnibus (GEO)
[17] and ArrayExpress [18]. We filtered data using the
criterion described in Section Methods, after which
we retained nine data sets. These data sets involved
five fungal pathogens, namely, Alternaria alternata,
Aspergillus fumigatus, Candida albicans, Pneumocystis
jirovecii, and Stachybotrys chartarum [19-24]. They cov-
ered seven target cell/tissue types including macrophages,
epithelial cells, dendritic cells, monocytes, neutrophils,
endothelial cells and lung cells, totaling 107 samples
(Table 1).
We computed biclusters using the procedure described
in Section Methods. Briefly, first, we computed gene sets
up- and down- regulated by each fungal pathogen using
Gene Set Enrichment Analysis (GSEA) [25]. Then, we
created two binary matrices for up- and down- regu-
lated gene sets, respectively. These matrices captured if
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Table 1 Description of gene expression data sets used in the study
ID Author(s) Acc # Pathogen Platform Target cell/tissue
H. sapiens
D1 Babiceanu et al. [*] GSE32893 A. alternata HG-U133_Plus_2 Epithelial
D2 Mezger et al. [19] GSE6965 A. fumigatus HG-U133_Plus_2 Dendritic
D3 Sharon et al. [21] GSE24983 A. fumigatus HG-U133A_2 Epithelial
D4 Mattingsdal et al. [*] E-MEXP-1103 A. fumigatus HG-U133_Plus_2 Monocytes
D5 Rubin-Bejerano et al. [*] E-MEXP-914 C. albicans HG-U133A_2 Neutrophils
D6 Rizzetto et al. [22] E-MTAB-135 C. albicans Illumina HumanHT-12 v3.0 Dendritic
D7 Müller et al. [23] GSE7355 C. albicans HG-U133A Endothelial
R. norvegicus
D8 Cheng et al. [24] GSE20149 P. jirovecii RG_U34A Macrophages
M.musculus
D9 Shimodaira et al. [*] GSE23178 S. chartarum Mouse430_2 Lung
The columns from left to right are (i) data set id, (ii) authors and the publication associated with the data set, (iii) GEO or ArrayExpress accession number, (iv) pathogen
name, (v) microarray platform, and (vi) cell/tissue type from which gene expression measurements were taken. Data sets are categorized by the host, namely, H.
sapiens, R. norvegicus andM.musculus. [*] indicates the data set that does not have an associated publication.
a gene set was perturbed or unperturbed by a pathogen
to a statistically significant extent. We biclustered these
matrices using Bimax biclustering software [26] in order
to identify subsets of fungal pathogens that commonly
up- or down- regulated subsets of gene sets. We obtained
27 up-regulated and 13 down-regulated biclusters
(see Additional file 1: Table S1 and Table S2 on sup-
plementary website for details on these biclusters). We
assessed the statistical significance of the biclusters by
comparing their sizes to biclusters found in randomized
data sets. After multiple hypothesis correction using the
method of Benjamini and Hochberg [27], we retained
three significant biclusters (two up-regulated and one
down-regulated) at a 0.05 p-value cutoff (Table 2). All the
significant biclusters contained two pathogens, namely, A.
fumigatus and C. albicans. Among the two significantly
up-regulated biclusters, we noticed that there were more
Table 2 Statistically significant biclusters
ID Pathogens Bicluster Number of
p-value gene sets
Up-regulated
B1 A. fumigatus (D3) and C. albicans (D6) < 10−5 204
B2 A. fumigatus (D2) and C. albicans (D6) < 10−5 174
Down-regulated
B3 A. fumigatus (D3) and C. albicans (D6) < 10−5 133
This table shows the bicluster that are statistically significant at a 0.05 p-value
cutoff. The columns from left to right are: (i) bicluster identification code, (ii) list
of pathogens contained in the biclusters. The text in parentheses indicate the
gene expression data identification code (see Table 1), (iii) a p-value indicating
the statistical significance of the bicluster, (iv) the number of gene sets in the
bicluster. The table shows up- and down- regulated biclusters.
up-regulated gene sets in bicluster B1 than in biclus-
ter B2. We reasoned that this difference arose from the
variation in the target cell type used in A. fumigatus infec-
tion, since the C. albicans data sets in the two biclusters
were identical. The A. fumigatus data in bicluster B1
was derived from lung epithelial cells whereas the one in
bicluster B2 was derived from dendritic cells (Table 1).
Epithelial cells of the lung are the primary entry points for
A. fumigatus infection. A. fumigatus has been shown to
adhere to and enter epithelial cells of the lung in order to
escape the hosts’ resident phagocytic cells [28]. We rea-
soned this fact may explain why A. fumigatus perturbed
more genes in epithelial cells as compared to in dendritic
cells. Hence, in this paper we decided to focus our dis-
cussion on up-regulated bicluster B1 and down-regulated
bicluster B3.
Pathogens may commonly perturb a gene set with-
out perturbing a single gene in common. Therefore, we
started our analysis by detecting if gene sets perturbed
by A. fumigatus and C. albicans share common genes. To
this end, we considered the leading edge genes of each
gene set perturbed by each pathogen. As computed by
GSEA, the leading edge genes for a gene set-pathogen
pair constitute those genes that contribute the most to
perturbation of a gene set by a pathogen [25]. We com-
puted the intersection of leading edge genes for the two
pathogens for each gene set in biclusters B1 and B3.
We retained 115 gene sets in up-regulated bicluster B1
and 49 gene sets in down-regulated bicluster B3 whose
leading edge in the two pathogens have a non-empty
intersection.
Next, we ranked the remaining gene sets in increasing
order of McNemar’s Chi-squared statistic. We used this
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statistic tomeasure whether or not the two pathogens per-
turbed different numbers of genes in each gene set. We
focused on gene sets where both pathogens perturbed the
same number of genes; i.e with small value of this statistic.
We called such gene sets consistently perturbed gene sets
(see Methods).
We hypothesize that such consistently perturbed gene
sets represent common host responses against the
pathogens A. fumigatus and C. albicans, and that
they may contain genes with the potential to serve
as immunomodulators. We selected 19 gene sets from
bicluster B1 and three gene sets from bicluster B3 that
have a McNemar’s test statistic value of zero (Table 3).
Then, we re-ranked these gene sets in increasing order of
the number of genes commonly perturbed by A. fumiga-
tus and C. albicans. Among these gene sets, we selected
the top-ten gene set from up-regulated bicluster B1 and all
three gene sets from down-regulated bicluster B3 (a total
of 13 gene sets) for discussion in this paper (Table 4).
We organize our results into two sections:
1. We evaluated the putative immunomodulatory
activity of the 13 selected gene sets and the genes they
contain, based on evidence found in the literature.
2. We grouped gene sets/genes depending on whether
they induced or repressed immune response, based
on the observation made in Step 1. Immune
response-inducing gene sets/genes represent up- or
down- regulated gene sets/genes that would make
the host more tolerant to infections by A. fumigatus
and C. albicans, while immune response-repressing
gene sets/genes are those that would have an
opposite effect when up- or down- regulated. We
generated a network of these gene sets/genes and
analyzed their combined immunomodulatory roles.
Predicted immunomodulatory activity
Most immunocompetent humans are immune to infec-
tions caused by A. fumigatus and C. albicans. The innate
and adaptive immune systems of the host are versatile
enough to prevent infection by these microorganisms.
The host becomes prone to infection only when one or
more of the immune system components such as phys-
ical barriers, cellular or humoral components are com-
promised [29,30]. Consistently and commonly perturbed
gene sets represent biological processes that are important
for pathogen survival or for defending the host from being
invaded by a pathogen. In other words, these gene sets are
important for maintaining the balance between pathogen
clearance, colonization and invasion. Identification of
these host responses is the first step in the search for
immunotherapies that are effective against both A. fumi-
gatus and C. albicans. Augmenting these host responses
may assist an immunocompromised individual in the fight
against these pathogens. Guided by these hypotheses, we
examined the 13 highly consistently and commonly per-
turbed gene sets identified earlier (Table 4). These gene
sets contain a total of 41 unique genes. Below we discuss
the potential immunomodulatory activity of these genes
in relation to the gene sets to which they belong, based on
evidence found in the literature.
Adaptive immune response
In the “Adaptive immune response” (GO:0002460) gene
set, A. fumigatus and C. albicans commonly up-
regulated the mucosa-associated lymphoid tissue lym-
phoma translocation gene 1 (MALT1) (Table 4). MALT1
is involved in the activation of Th-17 based adaptive
anti-fungal immunity. This process involves the following
steps: Zymosan, a component of the fungal cell wall, acti-
vates dectin-1, a pattern recognition receptor in the host.
This interaction induces a protein scaffold consisting of
caspase recruitment domain 9 (Card9), B cell lymphoma
10 (Bcl10) and Malt1 [31]. Specifically, the activation of
Malt1 is responsible for the activation of the c-Rel com-
ponent of NF-κB, which then induces Th-17 polarizing
cytokines such as IL-1β and IL-23 [32].
Inhibition of MALT1 has been shown to prevent c-
Rel activation and Th-17 immunity in human primary
dendritic cells infected with Candida species [33]. Th-
17 cells secrete IL-17, which is important for mobiliz-
ing neutrophils against fungal infections [32]. Gringhuis
et al. [32] have experimentally verified the importance of
Malt1 in the induction of adaptive immunity against var-
ious species of Candida. In addition, they pointed out
that a similar mechanism may have the same effect in
A. fumigatus infection, due to the presence of glucans
in both the cell wall of C. albicans and A. fumigatus.
Our analysis supports their premise that up-regulation of
MALT1 might be a common host response mechanism
against A. fumigatus and C. albicans. Hence, we hypothe-
size that increasing the expression of MALT1 might help
to promote pathogen recognition by dectin-1 and may
serve as a viable strategy for immune responsemodulation
(Figure 1).
Dissolution of fibrin clot
Dissolution of fibrin clot (also known as fibrinolysis) refers
to the degradation of fibrin. The main enzyme in this
process is plasmin. Plasmin is obtained when the precur-
sor plasminogen is converted to plasmin by plasmino-
gen activators. However, the conversion of plasminogen
to plasmin can be inhibited by plasminogen-activator
inhibitors [34].
Previous studies have linked the activation of plas-
min and hence fibrinolysis to increased pathogenicity of
both A. fumigatus and C. albicans. The binding of Can-
dida to the host’s plasmin via its surface cell receptors
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Table 3 Consistently perturbed gene sets
Gene set |A ∩ C| |A \ C| |C \ A| ∣∣A′ ∩ C′∣∣ |n|
Up-regulated
Adaptive immune response (MsigDB) 1 4 4 15 24
Dissolution of fibrin clot (NCI) 2 1 2 3 8
Granulocytes pathway (BIOCARTA) 3 0 1 10 14
Inactivation of MAPK activity (MsigDB) 3 1 1 9 14
Viral genome replication (MsigDB) 3 2 2 14 21
Hedgehog pathway up (NETPATH) 3 2 1 16 22
Positive regulation of immune response (MsigDB) 3 3 2 21 29
CD28 dependent PI3K AKT signaling (REACTOME) 4 2 3 10 19
Peptidyl tyrosine phosphorylation (MsigDB) 4 5 6 12 27
CDMAC pathway (BIOCARTA) 5 2 3 6 16
CARDIACEGF pathway (BIOCARTA) 5 3 3 7 18
CHUKNFKB2 REL IKBKG SPAG9NFKB1NFKBIE COPB2 TNIP1 NFKBIA RELA
TNIP2 complex (CORUM)
6 1 2 3 12
CD40 pathway (BIOCARTA) 7 1 1 6 15
EGFR1 pathway down (NETPATH) 8 13 13 64 98
NFKAPPABcanonicalpathway (NCI) 9 2 3 10 24
TRAF6 mediated induction of the antiviral cytokine IFN alpha beta
cascade (REACTOME)
10 7 6 30 53
Negative regulation of apoptosis (MsigDB) 19 18 19 91 147
MAPK signaling pathway (KEGG) 24 34 34 175 267
Signaling in immune system (REACTOME) 28 47 47 244 366
Down-regulated
LSM1-7 complex (CORUM) 4 2 1 0 7
Respiratory chain complex I (incomplete intermediate) mitochondrial
(CORUM)
4 3 4 0 11
Mitochondrial respiratory chain (MsigDB) 8 7 7 2 24
The columns from left to right are: (i) gene set name, (ii) |A ∩ C|: the number of genes in the gene set perturbed by both A. fumigatus and C. albicans, (iii) |A \ C|: the
number of genes perturbed by A. fumigatus but not by C. albicans, (iv) |C \ A|: the number of genes perturbed by C. albicans but not by A. fumigatus, (v) ∣∣A′ ∩ C′∣∣: the
number of genes unperturbed by both pathogens, and (vi) |n|: the total number of genes in a gene set. For each gene set, we have indicated the source database in
parentheses. This table shows gene sets that have a McNemar’s test statistic value of zero.
resulted in an increased ability to cross an in-vitro blood-
brain barrier [35]. Urokinase plasminogen activator (uPA)
and urokinase plasminogen activator receptor (uPAR),
agents that convert plasminogen to plasmin, were up-
regulated when human monocytes were co-cultured with
A. fumigatus [36].
In our study, A. fumigatus and C. albicans up-regulated
the genes serpin peptidase inhibitor clade E mem-
ber 1 (SERPINE1) and plasminogen activator urokinase
receptor (PLAUR) in the “Dissolution of fibrin clot”
(NCI-PID) gene set (Table 4). PLAUR encodes for the
receptor of uPA and SERPINE1 is an inhibitor of tis-
sue plasminogen activator (tPA) and uPA. The genes
SERPINE1 and PLAUR counteract each other, in that
PLAUR tends to increase the level of plasmin while
SERPINE1 tends to inhibit plasmin formation. The up-
regulation of these two genes in our analysis might indi-
cate competition between the host and the pathogen
where A. fumigatus and C. albicans attempted to cre-
ate a favorable environment for their pathogenicity,
while the host reacts to overcome this process. This
observation led us to speculate that up-regulating SER-
PINE1 and/or down-regulating PLAUR may help an
immunocompromised individual to become more toler-
ant to infections caused by either of these pathogens
(Figure 2).
Granulocytes pathway
A. fumigatus and C. albicans up-regulated three genes,
namely, intercellular adhesion molecule 1 (ICAM1),
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Table 4 Top-ten consistently perturbed gene sets
Gene set Genes
Up-regulated
Adaptive immune response (MsigDB) MALT1
Dissolution of fibrin clot (NCI) SERPINE1, PLAUR
Granulocytes pathway (BIOCARTA) ICAM1, IL8, IL1A
Inactivation of MAPK activity (MsigDB) DUSP8, DUSP6, SPRED2
Viral genome replication (MsigDB) TNIP1, CCL2, IL8
Hedgehog pathway up (NETPATH) PMP22, THBD, MYC
Positive regulation of immune response (MsigDB) FYN, EREG, MALT1
CD28 dependent PI3K AKT signaling (REACTOME) MAP3K14, FYN, TRIB3, MAP3K8
Peptidyl tyrosine phosphorylation (MsigDB) CLCF1, STAT1, IL12A, LYN
CDMAC pathway (BIOCARTA) NFKB1, NFKBIA, FOS, MYC, RELA
Down-regulated
LSM1-7 complex (CORUM) LSM4, LSM6, LSM2, LSM7
Respiratory chain complex I incomplete intermediate mitochondrial (CORUM) NDUFS6, NDUFV2, NDUFS4, NDUFS7
Mitochondrial respiratory chain (MsigDB) UQCRC1, NDUFAB1, BCS1L, NDUFS4, NDUFS7, NDUFS3, NDUFS8, SURF1
Top-ten consistently perturbed gene sets, ranked by the number of genes they contain for up- and down- regulated gene sets.
interleukin 8 (IL-8) and interleukin 1 alpha (IL-1α)
in the “Granulocytes pathway” (BIOCARTA) gene set
(Table 4). Adhesion molecules play an important role
in the host defense mechanism against pathogens. Oral
epithelial cells have been shown to induce ICAM1
in order to recruit and maintain neutrophils during
infection by Actinobacillus actinomycetemcomitans and
Porphyromonas gingivalis [37]. Inhibition of ICAM1 has
been shown to hinder adherence of C. albicans to
human gingival epithelial cells (HGECs) and resulted
in decreased secretion of IL-8, an important pro-
inflammatory molecule secreted during A. fumigatus and
C. albicans infections [38-40]. Another study linked the
up-regulation of IL-1α with the secretion of IL-8 in
oral epithelial cells infected with C. albicans [41]. All
these studies indicated the common role of ICAM1,
IL-8 and IL-1α in the host defense against pathogens.
Our analysis further supports published studies show-
ing that the up-regulation of the granulocytes path-
way, in particular of these three genes, may be an
Figure 1 Immunomodulation of Th-17 adaptive immunity.
Immunomodulation of Th-17 adaptive immunity using MALT1. The
figure shows the cascade of events in the malt1 dependent activation
of Th-17 type adaptive immunity.
important aspect of the host’s defense against infections
caused by A. fumigatus and C. albicans. We suggest
that ICAM1, IL-8 and IL-1α as candidates for a host-
oriented therapy that exploits the importance of granu-
locytes pathway.
Figure 2 Immunomodulation of the dissolution of fibrin clot.
Immunomodulation of the dissolution of fibrin clot by using
SERPINE1 and PLAUR genes. The figure shows a simplified model of
the dissolution of fibrin clot and the involvement of the genes
SERPINE1 and PLAUR in this process.
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Inactivation ofmapk activity
Mitogen-activated protein kinases (MAPKs) encompass a
group of protein kinases that regulate a number of cel-
lular processes ranging from cellular differentiation and
proliferation to apoptosis. Extracellular signal-regulated
kinases (ERKs) such as ERK1, ERK2, and ERK3 were
among the first recognized MAPKs in mammals [42].
Inactivation ofMAPKs has a negative effect on the normal
functioning of host systems including immune responses.
For instance, Dubourdeau et al. indicated that inactivation
of MAPK/ERK correlates with a decrease in the activa-
tion of innate immunity against A. fumigatus in a mouse
model [43].
In our analysis, A. fumigatus and C. albicans commonly
up-regulated three members of the “Inactivation of mapk
activity” (GO:0000188) gene set, namely, dual specificity
phosphatase 6 (DUSP 6), dual specificity phosphatase 8
(DUSP8), and sprouty-related EVH1 domain-containing 2
(SPRED2) genes (Table 4). DUSP6 and DUSP8 are known
negative regulators of MAPK activity [44]. Another study
indicated that SPRED2 negatively regulates growth factor-
mediated ERK signaling and hematopoiesis [45]. Given
these observations, we hypothesize that the up-regulation
of the “Inactivation of mapk activity” gene set might make
the host more vulnerable to infections caused by A. fumi-
gatus and C. albicans, and that the genes DUSP6, DUSP8
and SPRED2 might play a vital role in this aspect. Hence,
modulating the expression or activities (phosphorylation
status) of these gene products or downstream targets may
work to maintain cellular signaling via MAPKs.
Viral genome replication
The “Viral genome replication” (GO:0019079) gene set
annotates 21 genes. Among these genes, A. fumigatus
and C. albicans commonly up-regulated the genes mono-
cyte chemotactic protein-1 (MCP-1), TNFAIP3 interact-
ing protein 1 (TNIP1), and interleukin 8 (IL-8) (Table 4).
We have discussed the positive role of up-regulation of
IL-8 in the host defense against A. fumigatus and C.
albicans under the “Granulocytes pathway” gene set. Like-
wise, activation of MCP-1 (CCL2) has been shown to have
a positive role in the host defense against aspergillosis
and candidiasis. Neutralizing the MCP-1 gene resulted in
increased mortality and pathogen burden in the lungs of
mice with invasive aspergillosis [46]. MCP-1 was also pro-
duced by oral and vaginal epithelial cells when challenged
with C. albicans [47]. TNIP1, through its interaction with
tumor necrosis factor α-induced protein 3 (TNFAIP), is
able to inhibit NF-κB [48,49]. The inhibition of NF-κB is
reported to decrease the number of neutrophils as well as
the phagocytic and microbicide capacity against C. albi-
cans [50]. Hence, in this gene set, while the up-regulation
of IL-8 and MCP-1 might help the host to better toler-
ate the damage caused by A. fumigatus and C. albicans,
down-regulation of TNIP1 might be advantageous to the
host.
Hedgehog pathway up
The hedgehog (Hh) signaling pathway (NETPATH) regu-
lates the expression of genes that are important for various
cellular processes including growth, cell cycle regulation
and embryogenesis [51]. In this pathway, A. fumigatus
and C. albicans up-regulated the genes peripheral myelin
protein 22 (PMP22), thrombomodulin (THBD), andMYC
(Table 4). We did not find evidence in the literature that
linked the Hh signaling pathway to fungal infection. How-
ever, a recent study showed that up-regulation of this bio-
logical pathway increased cellular permissiveness in hep-
atitis C infection [52]. Paya et al. [53] indicated that fungal
infections such as those caused by Candida spp. and
hepatitis infections reoccur in liver transplant patients,
which may suggest an indirect association between the
up-regulation of the Hh signaling pathway and the patho-
genesis ofC. albicans. Guided by this observation, we pro-
pose that the up-regulation of this pathway might result
in increasing the pathogenesis of opportunistic infections
such as those caused by A. fumigatus and C. albicans.
Thus, down-regulation of this pathway may be a plausible
therapeutic approach to test.
Positive regulation of immune response
In the “Positive regulation of immune response”
(GO:0050778) gene set, A. fumigatus and C. albicans
commonly up-regulated the genes tyrosine-protein kinase
FYN, epiregulin (EREG) and mucosa associated lymphoid
tissue lymphoma translocation gene 1 (MALT1) (Table 4).
We have discussed the role of MALT1 in the activation of
Th-17 host immunity (see the section on the “Adaptive
Immune Response” gene set). Experimental evidence has
suggested that the up-regulation of FYN and EREG is
associated with an increase in the host’s defense against
A. fumigatus and C. albicans. FYN is involved in the
control of Th1-Th2 type cellular differentiation. Kudlacz
et al. [54] showed that FYN-knockout mice exhibited an
increase in Th2-type immune response and a decrease in
allergic airway inflammation. A shift in the host’s immune
response towards Th2-type will generally aggravate inva-
sive aspergillosis as well as invasive candidiasis [16].
This observation suggests that the up-regulation of FYN
might be linked to the maintenance of the host’s Th1 type
immunity. Th1 type immune response is an integral com-
ponent of host response in the protection against both
A. fumigatus and C. albicans [55,56]. In addition EREG,
which encodes for epiregulin (a protein involved in the
formation of epidermal growth factor receptor agonist),
plays a vital role in the proliferation of immune cells such
as macrophages [57]. EREG is up-regulated when alveolar
macrophages are challenged with A. fumigatus [58]. The
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up-regulation of FYN and EREG by A. fumigatus and C.
albicans in our analysis, might indicate the hosts attempt
to shift towards a Th1 type immune response and an
increase in the proliferation of phagocytic cells.
Cd28 dependent Pi3K Akt signaling
Phosphatidylinositol 3-kinase (PI3K) signaling is among
the first signal transduction events that occurs when an
antigen interacts with host cell surface receptors. Acti-
vated PI3K will recruit pleckstrin homology domain-
containing proteins such as Akt to initiate the PI3K/Akt
signaling cascade. PI3K/Akt signaling plays an important
role in various cellular activities ranging from cellular
differentiation to motility [59].
The “Cd28 dependent Pi3K Akt signaling” (REAC-
TOME) gene set contains 19 annotated genes. Among
these, the genes mitogen-activated protein 3 kinase
8 (MAP3K8), mitogen-activated protein 3 kinase 14
(MAP3K14), tyrosine-protein kinases FYN and tribbles
homolog 3 (Drosophila) (TRIB3) were commonly up-
regulated by A. fumigatus and C. albicans (Table 4).
We have discussed the role of FYN in the regulation of
Th1-Th2 type immune response earlier (see section on
“Positive regulation of immune response” gene set).
MAP3K8 is known to activate extracellular signal-
regulated kinases (ERKs). MAP3K8-deficient mice exhib-
ited low levels of TNF-α and ERK production [60].
Similarly, MAP3K14 also participates in ERK signaling
[61]. The activation of MAPK/ERK is important in the
recognition of A. fumigatus by innate immunity [43]. The
fourth gene perturbed in this gene set is TRIB3. Schwarzer
et al. [62] have shown that TRIB3 is up-regulated when
there is a shortage of nutrient supplies in cells. With
this observation in mind, we reasoned that the the up-
regulation of the “Cd28 dependent Pi3K Akt signaling”
gene set is part of the host defense mechanism against
the two pathogens. An immunomodulation strategymight
focus on the four genes discussed above.
Peptidyl tyrosine phosphorylation
The “Peptidyl tyrosine phosphorylation” (GO:0018108)
gene set annotates 27 genes. Among these genes, A.
fumigatus and C. albicans commonly up-regulated the
genes signal transducer and activator of transcription 1
(STAT1), cardiotrophin-like cytokine factor 1 (CLCF1),
interleukin 12A (IL12A), and v-yes-1 Yamaguchi sarcoma
viral related oncogene homolog (LYN). STAT1 plays a vital
role in the induction of Th17 and Th1 type host immune
responses. It encodes for an adapter molecule that is
important for the activation of the IL-23 (IL23R) and IL-
12 (IL12R) receptor pathways. IL23R and IL12R are vital
in inducing Th-17 and Th-1 type immune responses. Pre-
vious studies indicated that mutation in STAT1 resulted
in defective Th-17-type and Th-1-type responses [63,64].
Hence, this gene set may have a positive role in the host
defense mechanism.
Cdmac pathway
The cadmium-induced DNA synthesis and proliferation
in macrophages (CDMAC) pathway (BIOCARTA) con-
tains 16 annotated genes that were dysregulated when
macrophages were exposed to cadmium ions (Cd2+).
Among these genes, A. fumigatus and C. albicans com-
monly up-regulated five genes namely, NFKB1, RELA,
NFKBIA, FOS, and MYC. Cadmium induces both cellular
proliferation promoting and immune response inhibiting
genes. The cellular proliferation genes include NFKB1,
REL1, FOS, and MYC. NFKB1 and REL1 are involved in
the formation of NF-κB complexes and NFKBIA is an
inhibitor of NF-κ-B/REL complexes [65]. Taken together,
the up-regulation of this gene set supports the common
observation regarding the proliferation of macrophages in
response to attempted infection.
Lsm1-7 complex
The “Lsm1-7 complex” (CORUM) gene set annotates
seven genes that are involved in mRNA degradation [66].
Among these genes A. fumigatus and C. albicans com-
monly down-regulated four genes, namely, LSM4, LSM6,
LSM2, and LSM7 (Table 4). Unstable mRNA degrada-
tion has been linked to a number of diseases including
the inflammatory disease, arthritis [67]. Previous studies
also indicated the potential regulation of mRNA stabil-
ity in the treatment of a wide range of diseases including
those caused by infectious pathogens [68,69]. The down-
regulation of genes related to mRNA degradation in our
analysis might be linked to the pathogenesis of A. fumi-
gatus and C. albicans. The genes LSM4, LSM6, LSM2,
and LSM7 are potential candidates for an immunological
strategy that targets the LSM1-7 complex in countering
these two pathogens.
Mitochondrial respiratory chain and respiratory chain
complex I mitochondrial
About 90% of cellular energy, in the form of adenosine-tri-
phosphate (ATP), is produced inside mitochondria. Mito-
chondria also play a vital role in cellular processes such
as the regulation of reactive oxygen, calcium homeostasis,
programmed cell death and metabolic processes. The
classical mitochondrial respiratory chain is composed of
four complexes (Complex I-IV) [70]. A. fumigatus and C.
albicans down-regulated 10 unique genes in the “Mito-
chondrial Respiratory Chain” (GO:0005746) and “Respi-
ratory Chain Complex I Mitochondrial” (CORUM) gene
sets. Studies have shown that mitochondrial respiratory
chain has an important role in antiviral processes. A
decrease in Coxsackievirus B3 (CVB3) viral load was
observed with an increase in mitochondrial complexes I
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in a mouse model [71]. Although we did not find liter-
ature evidence describing the role of the mitochondrial
respiratory chain in bacterial and fungal infections, the
perturbation of this gene set, in our analysis, may shed
some light on its importance. The down-regulation of the
mitochondrial respiratory chain gene set might favor the
pathogenesis of A. fumigatus and C. albicans.
Immune response-inducing and -repressing gene sets
In the preceding section, we discussed the immuno-
logical relevance of 13 consistently and commonly per-
turbed gene sets. Among these gene sets, we observed
that the up-regulation of seven gene sets namely, “Adap-
tive immune response”, “Granulocytes pathway”, “Viral
genome replication”, “Positive regulation of immune
response”, “Cd28 dependent Pi3K Akt signaling”, “Pep-
tidyl tyrosine phosphorylation”, and “Cdmac pathway”
favor the host immune response. On the other hand,
the up-regulation of gene sets such as “Dissolution
of fibrin clot”, “Inactivation of mapk activity” and
“Hedgehog pathway up” and the down-regulation of
“Lsm1-7 complex”, “Respiratory Chain Complex I Mito-
chondrial”, and “Mitochondrial Respiratory Chain” dis-
favor the host immune response. In the same way, the
perturbed genes also fall into two groups. For instance,
genes such as MALT1, SERPINE1, ICAM1, and IL8
have a positive impact on the immune response when
up-regulated, while the up-regulation of genes such as
DUSP8, DUSP6 and SPRED2 may negatively impact the
host immune response. We refer to the first set of gene
sets/genes as immune response-inducing and to the sec-
ond set as immune response-repressing gene sets/genes.
We generated a network of these gene sets using the
Markov Chain Monte Carlo-Biological Process Networks
(MCMC-BPN) method developed by Lasher et al. [72]
(Figure 3). Given gene expression data, protein-protein
interactions, functional annotations of genes, and a set of
biological processes, MCMC-BPN first creates a network
among all pairs of processes that cross annotate at least
one gene. Then, it seeks to find the smallest number of
process links that explain as many as perturbed interac-
tions as possible. We also created a functional interac-
tion network among the genes using Cytoscape [73] and
data obtained from the STRING database [74] (Figure 4).
The goal is to identify highly interacting gene sets and
genes, upon which we can prioritize immunomodulatory
strategies. We noticed that “Cd28 dependent Pi3K Akt
signaling” and “Cdmac pathway” are the top-two highly
connected gene sets (Figure 3). In addition, genes such as
such as NF-κB1 and LSM-7 havemany interactors. In gen-
eral, an immunomodulatory strategy against A. fumigatus
and C. albicans might focus on increasing the expression
level of genes in the immune response-inducing category
and/or suppressing immune response-repressing genes.
Methods
Gene expression data sets
We obtained 307 distinct taxonomic names of fungal
pathogens from Woolhouse and Gowtage-Sequeria [1].
We queried the GEO meta database [17] and ArrayEx-
press [18]) using these taxonomic names as keywords. We
filtered the data using the following criterion. In short, we
removed time-course data, we excluded data sets with less
than six samples, we retained data only from three host
species namely, Homo sapiens, Mus musculus and Rat-
tus norvegicus, and we removed data that did not involve
healthy and infected samples. We obtained nine data
sets. The data sets spanned across five fungal pathogens,
namely, A. alternata, A. fumigatus, C. albicans, P. jirovecii,
and S. chartarum, and seven target cell/tissue types
including macrophages, epithelial, dendritic cells, mono-
cytes, neutrophils, endothelial cells, and lung (Table 1).
We downloaded gene expression data and normalized
using the GC Robust Multi-array Average (GCRMA)
procedure.
Functional annotations
Functional annotation data sets were collected from four
sources namely, National Cancer Institute-Nature Path-
way Interaction Database (NCI-PID), NetPath database
(NetPath), CORUM Database of Mammalian Protein
Complexes (CORUM), andMolecular Signature Database
(MsigDB). Collectively these were referred to as gene sets
in our analysis.
Computation of bicluster genes
In GSEA, the leading edge genes for a gene set-pathogen
pair (GSi,Pj) is defined as the set of genes that contribute
the most to the perturbation of a gene set by a pathogen.
The leading edge genes for a gene set constitute those
genes that appear in the ranked list of genes at or before
the point where the running sum reaches its maximum
deviation from zero [25]. On the basis of the leading edge
genes, we intended to define bicluster genes which can
be interpreted as the core of gene sets that accounts for
the perturbation of the gene sets by the pathogens in a
bicluster.
Consider a bicluster b that consists of m gene sets
and n pathogens, and let Li,j be the set of leading edge
genes for the ith gene set and jth pathogen in b. We
computed the set of bicluster genes in the following way:
First, found the intersection of the sets Li,j across all the
pathogens for each gene set in a bicluster, and we denoted
the resulting set by Li. Then, we found the union of
the sets Lis across all member gene sets which gave us
bicluster genes denoted by BGb. Table 5 demonstrates this
process for a bicluster that contains two gene sets and
two pathogens.
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Figure 3 Network of gene sets. A network of immune response-inducing and -repressing gene sets. Gene sets are represented with rectangles.
Gene sets are connected by an edge if they are interacting.
Computation of consistently and commonly perturbed
gene sets
Pathogens may not perturb gene sets in a bicluster in the
same manner, i.e., the number of perturbed genes may be
skewed towards one of the pathogens, or the perturbation
may be similar across the two pathogens, assuming two
pathogens in a bicluster.We intended to discover gene sets
where the number of genes perturbed by two pathogens
remained similar. We converted this into a contingency
table as shown in Figure 5. We used the McNemar’s
Figure 4 Network of genes. A network of immune response-inducing and -repressing genes. In this diagram, circles represent immune
response-inducing genes and hexagons represent immune response-repressing genes. Genes are connected by an edge if they are functionally
interacting (interaction information was obtained from the STRING database [74]).
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Table 5 Computation of bicluster genes
P1 P2
GS1 L11 ∩ L12 L1
∪
GS2 L21 ∩ L22 L2
BGb
Computation of bicluster genes for a 2X2 bicluster. Li,j represents the
leading-edge genes for a pathogen-gene set pair. Li represents leading edge
genes for the ith gene set over all the pathogens in the bicluster. BGb represents
the bicluster genes for bicluster.
chi-square test statistic as an assessment criterion [75].
A smaller test statistic result indicated that the number
of perturbed genes was similar for the two pathogens
whereas a larger test statistic indicated that the number
of genes perturbed by the two pathogens are dissimilar.
For a contingency table such as that shown in Figure 5,
the McNemar’s chi-square test statistic is given by the for-
mula shown below. According to R Statistical Package, a
McNemar’s chi-squared value of less than one is rounded
to zero.




In this study, we used a combination of gene set enrich-
ment analysis and biclustering in the prediction of com-
mon immunomodulators that can potentially be activated
or repressed in order to make the host more tolerant
to fungal infections. Although this work leveraged on
existing computational techniques, to the best of our
knowledge, it is the first one to use similar computa-
tional approaches in the prediction of broad-spectrum
immunomodulators. In this study, we tried to address
one of the most important problems in the treatment
of infectious diseases, i.e. drug resistance. The current
paradigm in the fight against drug-resistance is targeting
host genes and proteins instead of pathogen targets. This
involves manipulating or subverting biological processes
in the host that pathogens utilize. We have developed a
computational approach for the identification of common
host response mechanisms, which is an important step in
host-oriented treatment paradigms.
Our approach is based on detecting consistently per-
turbed gene sets among gene sets commonly perturbed
by pathogens guided by McNemar’s chi-square test of
dependence. The hypothesis behind our approach is that
such gene sets might capture biological processes that
are commonly and consistently involved in the host-
pathogen interaction, and that such gene sets may contain
potential putative broad-spectrum immunomodulators.
Using this approach, we produced a ranking of gene
sets containing immunomodulators, although we focused
our analysis on ten highly consistently perturbed gene
sets.
In this study, we identified genes that are positively and
negatively correlated with the host immune response; we
called them immune response-inducing and -repressing
genes respectively (Table 6). Immune response -inducing
a b
c d
Figure 5 Contingency table of genes. Contingency table of perturbed/unperturbed genes by A. fumigatus and C. albicans, (a) |A ∩ C|: the
number of genes in the gene set perturbed by both A. fumigatus and C. albicans, (b) |C \ A|: the number of genes perturbed by C. albicans but not
by A. fumigatus, (c) |A \ C|: the number of genes perturbed by A. fumigatus but not by C. albicans, and (d) ∣∣A′ ∩ C′∣∣: the number of genes
unperturbed by both pathogens.
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Table 6 Predicted immunomodulatory activities
Gene Immunomodulatory Activity Pathogen Ref
Immune response-inducing genes
MALT1 Inhibition of MALT1 stopped c-Rel activation and Th-17 immunity to Candida species C. albicans [33]
SERPINE1 SERPINE1 Inhibits plasmin formation. Plasmin bound C. albicans showed increased invasiveness. C. albicans [35]
ICAM1 Inhibition of ICAM-1 stopped adherence of C. albicans to human gingival epithelial cells (HGECs) and
resulted in a decreased activation of pro-inflammatory cytokine IL-8
C. albicans [38]
IL8 see ICAM1 [38]
IL1A IL-1α from C. albicans infected oral epithelial cells up-regulated secretion IL-8 and granulocyte colony-
stimulating factor (GM-CSF)
C. albicans [41]
FYN FYN knockout mice were shown to have increased Th2 type immune response [54]
STAT1 Defects in STAT1 result in defective Th17-type and Th1-type responses [63,64]
CCL2 Neutralizing CCL2 resulted in increased mortality and pathogen burden in the lungs of mice with invasive
aspergillosis
A. fumigatus [46]
MAP3K8 MAP3K8 deficient mice exhibited low-level of TNF-α and ERK production [60]
MAP3K14 MAP3K14 Activated MAPKs [61]
NFKB1 Component of NF-κB
RELA Component of NF-κB
EREG EREG is important in the proliferation and differentiation of macrophages. It was up-regulated when alveolar
macrophages were challenged with conidia of A. fumigatus
A. fumigatus [58]
IL12A Central for the induction of TH1-type cytokines [63,64]
TRIB3 TRIB3 senses the presence of cellular nutrient in PI3K/AKT signaling [62]
CLCF1 Activates the Jak-STAT signaling cascade?
LYN Inhibiting the ICAM-1-binding activity?
Immune response-repressing genes
PLAUR PLAUR promotes plasmin formation. Plasmin bound C. albicans showed increased invasiveness. C. albicans [35]
DUSP8 DUSP8 inhibits MAPK/ERK. Inactivation of MAPK/ERK correlated with a decrease in the activation of innate
immunity against A. fumigatus in a mice model
A. fumigatus [43]
DUSP6 DUSP6 inhibits MAPK/ERK (see DUSP8)
SPRED2 SPRED2 inhibits MAPK/ERK (see DUSP8)
NFKBIA Inhibits NF-κB. Inhibition of NF-κ decreased neutrophil phagocytosis and microbicide capacity C. albicans [50]
TNIP1 Inhibits NF-κB [49]
PMP22 Up-regulation of Hedgehog pathway increased cellular permissiveness for hepatitis C virus replication [52]
THBD Up-regulation of Hedgehog pathway increased cellular permissiveness for hepatitis C virus replication [52]
Genes and their predicted immunomodulatory activities for up-regulated bicluster B1.
genes were genes whose up-regulation increased the host’s
immune response and immune response-repressing genes
had an opposite effect. We believe that the perturbation
of both groups of gene sets and genes are important in
maintaining the balance between clearance, colonization
and invasion in immunocompetent individuals.
Our approach has enabled the identification of previ-
ously known immunomodulators such as MALT1, sug-
gesting the validity of the computational techniques that
we implemented in this study. Currently, our analy-
sis is limited by the number of publicly available gene
expression data sets pertaining to host-response to fungal
infections. In the future, we hope to expand the approach
to includemore fungal pathogens as new data sets become
available. Also, our analyses suffer from heterogeneity in
the transcriptional data sets utilized in this study, e.g.,
microarray platforms, cell types, and temporal aspects.
We believe that standardized experimental designs may
improve the reliability and robustness of such analyses.
We acknowledge that tissue specificity is an important
aspect of host response. However, we did not find an
adequate number of data sets to investigate tissue spe-
cific responses. We found nine data sets that met our
selection criterion. These data sets spanned across seven
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target cell/tissue types including macrophages, epithe-
lial, dendritic cells, monocytes, neutrophils, endothelial
cells, and lung. The number of data sets was very small
and sparse to perform a statistically sound analysis per-
taining to tissue-specific host responses. However, the
computational method we developed is capable of detect-
ing tissue-specific host responses by computing biclusters’
enrichment in tissue/cell types. We demonstrated this in
our previous work on a large host response gene expres-
sion data set related to bacterial infection as shown on the
supplementary website [76].
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